Polaryx Therapeutics CEO’s Mstone buys $360,003 in PLYX stock
Source link
Related Posts
MasTec’s SWOT analysis: stock faces near-term headwinds but 2026 promise
MasTec’s SWOT analysis: stock faces near-term headwinds but 2026 promise Source link
Crinetics presents phase 2 data for CAH treatment atumelnant
Crinetics presents phase 2 data for CAH treatment atumelnant Source link
Asia markets brace for selling after tech rout hits Wall Street
Asia markets brace for selling after tech rout hits Wall Street Source link